Semaia, MDC research deal

Cancer therapeutics play Semaia (Berlin, Germany), a wholly-owned subsidiary of Semaia Pharmaceuticals Holdings (Utrecht, the Netherlands), will collaborate with Max-Delbrueck-Center for Molecular Bio...